---
title: "STAT+ briefing: The EPIC investigation overview and a Teladoc development"
id: "stat-news-1-stat-the-epic-investigation-and-a-teladoc-surprise"
canonical_url: "https://medichelpline.com/clinical-feed/stat-news-1-stat-the-epic-investigation-and-a-teladoc-surprise"
content_type: "clinical_feed_article"
specialty: "General"
source_name: "STAT News"
source_url: "https://www.statnews.com/2026/10/29/epic-investigation-teladoc-surprise-ai-payment-model-health-tech/?utm_campaign=rss"
published_at: "2026-10-29T16:15:20.000Z"
evidence_level: "Verified Feed"
license: "CC-BY-NC-4.0 / Informational Use"
---
# STAT+ briefing: The EPIC investigation overview and a Teladoc development
## Provenance & Clinical Metadata
- **Canonical URL:** https://medichelpline.com/clinical-feed/stat-news-1-stat-the-epic-investigation-and-a-teladoc-surprise
- **Specialty:** [General](https://medichelpline.com/clinical-feed/general.md)
- **Primary Source:** STAT News
- **Source URL:** [Original Journal Publication](https://www.statnews.com/2026/10/29/epic-investigation-teladoc-surprise-ai-payment-model-health-tech/?utm_campaign=rss)
- **Published At:** 2026-10-29T16:15:20.000Z
- **Evidence Rating:** Verified Feed
## Executive GIST (TL;DR)
- STAT published a subscriber-only Health Tech newsletter item headlined “The EPIC investigation, and a Teladoc surprise.” The full investigative reporting and specifics are behind the STAT+ paywall and not available in the public source. - The newsletter item is dated Oct. 29, 2026, and was authored by Mario Aguilar, STAT’s Health Tech correspondent. Aguilar’s beat includes FDA oversight of artificial intelligence, Medicare payment for health technology, and consumer health devices. - The publicly viewable page includes an image tied to **Teladoc** and refers to a “surprise,” but the source did not report the nature, data, or outcomes of that development. - The page references an ongoing probing of **Epic**’s market position; the story’s substantive findings, documentation, or evidence were not included in the source copy. - STAT flagged an upcoming live appearance: the outlet will host a session at the HLTH conference in Las Vegas on Nov. 18. That event reference appeared on the page without additional reporting detail. - The page contains subscription prompts, pricing tiers, and an explicit message that the rest of the story requires STAT+ access. No trial methodology, quotes from investigators, or specific regulatory or commercial ramifications were provided on the public page. - Contact and byline details for the reporter were included; Aguilar’s email address and social handles were listed. The source did not publish the investigative documents, datasets, or regulatory filings on the public page. - The publicly visible content lists related STAT reporting on Epic and other recent health tech items, but did not reproduce the underlying investigative material. Readers must subscribe to access full coverage and primary claims. - The page included navigation, advertising, and a gallery image credit, but the source did not supply additional empirical results, company statements, or timelines that would allow independent assessment. - Overall, the public source provides headline-level signals about an Epic investigation and an item involving Teladoc, but leaves the substantive assertions, evidence, and implications to the subscriber-only portion of the report.
## Clinical Analysis & Structured Key Points
[Skip to Main Content](https://www.statnews.com/2026/10/29/epic-investigation-teladoc-surprise-ai-payment-model-health-tech/?utm_campaign=rss#wrapper) [ ![STAT](https://www.statnews.com/wp-content/themes/stat/images/stat-logo-white.svg) ![STAT](https://www.statnews.com/wp-content/themes/stat/images/stat-logo.svg) ](https://www.statnews.com/) * [Manage alerts for this article](https://www.statnews.com/my-account/edit/#emails) * [Save this story for later](https://www.statnews.com/my-account/saved/) * [Share this article](https://www.statnews.com/2026/10/29/epic-investigation-teladoc-surprise-ai-payment-model-health-tech/?utm_campaign=rss) [Clinical trials](https://www.statnews.com/topic/clinical-trials/) [autoimmune](https://www.statnews.com/topic/autoimmune/) [research](https://www.statnews.com/topic/research/) * [Newsletters](https://www.statnews.com/signup/) * [Log In](https://www.statnews.com/login/) * [My Account](https://www.statnews.com/my-account/) * [Subscribe Now](https://www.statnews.com/stat-plus/) My Account * [Settings Complete your personal information for a more tailored experience ](https://www.statnews.com/my-account/) * [Saved Stories](https://www.statnews.com/my-account/saved/) * [Billing](https://www.statnews.com/my-account/billing/) * [Log In](https://www.statnews.com/login/) [ ![STAT](https://www.statnews.com/wp-content/themes/stat/images/stat-logo.svg) Reporting from the frontiers of health and medicine ](https://www.statnews.com/) * [Newsletters](https://www.statnews.com/signup/) * [Log In](https://www.statnews.com/login/) * [My Account](https://www.statnews.com/my-account/) * [Subscribe Now](https://www.statnews.com/stat-plus/) * [Biotech](https://www.statnews.com/category/biotech/) * [Pharma](https://www.statnews.com/category/pharma/) * [Public Health](https://www.statnews.com/category/health/) * [Health Tech](https://www.statnews.com/category/health-tech/) * [Policy](https://www.statnews.com/category/politics/) * [Science](https://www.statnews.com/category/in-the-lab/) * [First Opinion](https://www.statnews.com/category/first-opinion/) * [STAT+](https://www.statnews.com/topic/stat-plus/) * [Midterms 2026](https://www.statnews.com/midterms-2026-health-care-policy-issues/) [ ![STAT](https://www.statnews.com/wp-content/themes/stat/images/stat-logo.svg) ](https://www.statnews.com/) Search * [Log In](https://www.statnews.com/login/) * [Subscribe Now](https://www.statnews.com/stat-plus/) * [My Account](https://www.statnews.com/my-account/) My Account * [Settings](https://www.statnews.com/my-account/) * [Saved Stories](https://www.statnews.com/my-account/saved/) * [Billing History](https://www.statnews.com/my-account/billing/) [Home](https://www.statnews.com/) News * [Latest](https://www.statnews.com/latest/) * [Series & Investigations](https://www.statnews.com/stat-series-and-investigations-award-winning-journalism/) * Business * [Biotech](https://www.statnews.com/category/biotech/) * [Pharma](https://www.statnews.com/category/pharma/) * [Health Tech](https://www.statnews.com/category/health-tech/) * [Health Insurance](https://www.statnews.com/category/insurance/) * [Hospitals](https://www.statnews.com/category/hospitals/) * [Medical Devices](https://www.statnews.com/topic/medical-devices/) * Washington * [Policy](https://www.statnews.com/category/politics/) * [FDA](https://www.statnews.com/topic/fda/) * [NIH](https://www.statnews.com/topic/nih/) * Science * [CRISPR](https://www.statnews.com/topic/crispr/) * [Gene Therapy](https://www.statnews.com/topic/gene-therapy/) * [Neuroscience](https://www.statnews.com/topic/neuroscience/) * Public Health * [Addiction](https://www.statnews.com/topic/addiction/) * [Covid-19](https://www.statnews.com/topic/coronavirus/) * [Abortion](https://www.statnews.com/topic/abortion/) * [Health Disparities](https://www.statnews.com/topic/health-disparities/) * [Infectious Disease](https://www.statnews.com/topic/infectious-disease/) * [Mental Health](https://www.statnews.com/topic/mental-health/) * Disease * [Cancer](https://www.statnews.com/topic/cancer/) * [Cardiovascular Disease](https://www.statnews.com/topic/cardiovascular-disease/) * [Chronic Disease](https://www.statnews.com/topic/chronic-disease/) * [Diabetes](https://www.statnews.com/topic/diabetes/) * [Alzheimer's](https://www.statnews.com/topic/alzheimers/) * [Obesity](https://www.statnews.com/topic/obesity/) * Features * [Health Care Costs](https://www.statnews.com/health-insurance-costs-out-of-pocket-out-of-reach-series/) * [The Deadliest Drug](https://www.statnews.com/alcohol-epidemic-hiding-plain-sight-deadliest-drug-series/) * [Science, Shattered](https://www.statnews.com/american-science-shattered/) [Newsletters](https://www.statnews.com/signup/) [Opinion](https://www.statnews.com/category/first-opinion/) Columns * [Adam Feuerstein](https://www.statnews.com/category/adams-take/) * [Matthew Herper](https://www.statnews.com/category/matts-take/) * [Ed Silverman](https://www.statnews.com/category/pharmalot-view/) [Reports](https://reports.statnews.com/) [E-books](https://www.statnews.com/ebooks/) [Podcasts](https://www.statnews.com/podcasts/) [Tools & Trackers](https://www.statnews.com/trackers/) * [CRISPR Tracker](https://www.statnews.com/feature/crispr/tracker/) * [Breakthrough Device Tracker](https://www.statnews.com/feature/stat-plus/breakthrough-device-designation-fda-tracker/) * [Generative AI Tracker](https://www.statnews.com/feature/stat-plus/generative-ai-health-hospitals-tracker/) * [Obesity Drug Tracker](https://www.statnews.com/2023/09/12/new-weight-loss-drug-tracker-novo-nordisk-eli-lilly/) [Events](https://www.statnews.com/events/) * [Upcoming Events](https://www.statnews.com/events#upcoming-events) * [Summits](https://www.statnews.com/stat-summits/) [Community](https://www.statnews.com/community/) * [STAT Wunderkinds 2026](https://www.statnews.com/wunderkinds/) [Video](https://youtube.com/@Statnews) [Advertise](https://www.statnews.com/advertise/) * [STAT Brand Studio](https://sbs.statnews.com/) What's the word? Test your knowledge with our new weekday mini crossword [ Start solving ](https://www.statnews.com/stat-mini-crossword/) [STAT Plus](https://www.statnews.com/stat-plus/)Newsletter[Health Tech Newsletter](https://www.statnews.com/category/health-tech-newsletter/) # The EPIC investigation, and a Teladoc surprise ## You’re reading the web edition of STAT’s Health Tech newsletter * [Manage alerts for this article](https://www.statnews.com/my-account/edit/#emails) * [Save this story for later](https://www.statnews.com/my-account/saved/) * [Share this article](https://www.statnews.com/2026/10/29/epic-investigation-teladoc-surprise-ai-payment-model-health-tech/?utm_campaign=rss) ![Teladoc Health company logo displayed on mobile phone against a screen with numbers and arrows. -- health coverage from STAT](https://www.statnews.com/wp-content/uploads/2025/02/AdobeStock_812758606_Editorial_Use_Only-645x645.jpeg) Adobe ![](https://www.statnews.com/wp-content/uploads/2021/02/mario-a-avatar-small-80x80.png) By [Mario Aguilar](https://www.statnews.com/staff/mario-aguilar/) Oct. 29, 2026 Health Tech Correspondent ![](https://www.statnews.com/wp-content/uploads/2021/02/mario-a-avatar-small-80x80.png) [Mario Aguilar](https://www.statnews.com/staff/mario-aguilar/) 1. [](https://www.linkedin.com/in/mario-aguilar-13361235/ "Linkedin") 2. [](https://x.com/mariojoze "X") mario.aguilar@statnews.com Mario covers technology in health care, including FDA regulation of artificial intelligence; how Medicare pays for health tech; the use of AI in clinical care; mental health chatbots; and consumer wearables. He’s also the co-author of the free, twice weekly [STAT Health Tech newsletter](https://www.statnews.com/signup/health-tech/). You can reach Mario on Signal at mariojoze.13. Y _ou’re reading the web edition of STAT’s Health Tech newsletter, our guide to how technology is transforming the life sciences.[Sign up to get it](https://www.statnews.com/signup/health-tech/) delivered in your inbox every Tuesday and Thursday._ Good morning health tech readers! Advertisement **Big news: STAT is taking over a stage at[HLTH](https://hlth.com/events/usa/agenda/stat-at-hlth) in Las Vegas on the morning of Wednesday, Nov. 18.** STAT+ Exclusive Story Already have an account? [Log in](https://www.statnews.com/login/) ![STAT+](https://www.statnews.com/wp-content/themes/stat/images/stat-plus-breaker-bg.png) [ ![STAT+](https://www.statnews.com/wp-content/themes/stat/images/stat-plus-logo-white.svg) ](https://www.statnews.com/stat-plus/) ## This article is exclusive to STAT+ subscribers ### Unlock this article — plus in-depth analysis, newsletters, premium events, and news alerts. Already have an account? [Log in](https://www.statnews.com/login/) Individual plans Group plans Monthly $39 Totals $468 per year [$39/month](https://www.statnews.com/stat-plus/subscribe/?plan=stat-plus-monthly-39-0) [Get Started](https://www.statnews.com/stat-plus/subscribe/?plan=stat-plus-monthly-39-0) Totals $468 per year Starter $30 for 3 months, then $399/year [$30 for 3 months](https://www.statnews.com/stat-plus/subscribe/?plan=3mo30_yearly_pw) [Get Started](https://www.statnews.com/stat-plus/subscribe/?plan=3mo30_yearly_pw) Then $399/year Annual $399 Save 15% [$399/year](https://www.statnews.com/stat-plus/subscribe/?plan=stat-plus-annually-399-0) [Get Started](https://www.statnews.com/stat-plus/subscribe/?plan=stat-plus-annually-399-0) Save 15% 11+ Users Custom Savings start at 25%! [Request A Quote](https://www.statnews.com/stat-plus/group-subscriptions/) [Request A Quote](https://www.statnews.com/stat-plus/group-subscriptions/) Savings start at 25%! 2-10 Users $300 Annually per user [$300/year](https://www.statnews.com/stat-plus/subscribe/?plan=stat_plus_groups_self_serve_0) [Get Started](https://www.statnews.com/stat-plus/subscribe/?plan=stat_plus_groups_self_serve_0) $300 Annually per user [View All Plans](https://www.statnews.com/stat-plus/) [![STAT+](https://www.statnews.com/wp-content/themes/stat/images/stat-plus-logo.svg)](https://www.statnews.com/stat-plus/) To read the rest of this story subscribe to STAT+. [Subscribe](https://www.statnews.com/stat-plus/) [Log In](https://www.statnews.com/login/) [health tech](https://www.statnews.com/topic/health-tech/), [Health Tech Newsletter](https://www.statnews.com/topic/health-tech-newsletter/), [STAT+](https://www.statnews.com/topic/stat-plus/) [Submit a correction request](https://www.statnews.com/contact/?how_can_we_help_=Editorial%20Correction%20Request)[Reprints](https://www.parsintl.com/publications/stat/) 1. ![](https://www.statnews.com/wp-content/uploads/2021/02/mario-a-avatar-small-80x80.png) [Mario Aguilar](https://www.statnews.com/staff/mario-aguilar/) 1. [](https://x.com/mariojoze "X") 2. 3. [](https://www.linkedin.com/in/mario-aguilar-13361235/ "Linkedin") Health Tech Correspondent 1. [](https://x.com/mariojoze "X") 2. 3. [](https://www.linkedin.com/in/mario-aguilar-13361235/ "Linkedin") Mario covers technology in health care, including FDA regulation of artificial intelligence; how Medicare pays for health tech; the use of AI in clinical care; mental health chatbots; and consumer wearables. He’s also the co-author of the free, twice weekly [STAT Health Tech newsletter](https://www.statnews.com/signup/health-tech/). You can reach Mario on Signal at mariojoze.13. ![](https://www.statnews.com/wp-content/themes/stat/images/article-new/envelope-open.svg) ![](https://www.statnews.com/wp-content/uploads/2025/01/AIPrognosis_Wordpress_LogoMainSignupPage-640x108.png) ### STAT+ Newsletter A hitchhiker's guide to the health care AI galaxy Please enter a valid email address. Sign Up Your data will be processed in accordance with our [Privacy Policy](https://www.statnews.com/privacy/) and [Terms of Service](https://www.statnews.com/terms-conditions/). You may opt out of receiving STAT communications at any time. Advertisement Most Popular 1. ![](https://www.statnews.com/wp-content/uploads/2026/10/C0614545-Rheumatoid_arthritis_light_micrograph-80x80.jpg) ![](https://www.statnews.com/wp-content/themes/stat/images/home/statplus.svg) [After two deaths in autoimmune cell therapy trial, Artiva is shutting down](https://www.statnews.com/2026/10/27/autoimmune-cell-therapy-trial-artiva-therapeutics-shutting-down/) 2. ![](https://www.statnews.com/wp-content/uploads/2026/10/260921_GK_GerardAnderson009-2-80x80.jpg) [Hospital and pharmaceutical prices are smothering America’s businesses](https://www.statnews.com/2026/10/05/hospital-bills-drug-prices-insurance-premiums-spiral-part-5-out-of-pocket-series/) 3. ![](https://www.statnews.com/wp-content/uploads/2026/09/STAT_Epic_Competition_F1_3000_Cleaner-80x80.jpg) ![](https://www.statnews.com/wp-content/themes/stat/images/home/statplus.svg) [As Epic’s dominance grows, its iron grip is choking innovation in health technology](https://www.statnews.com/2026/10/28/epic-systems-ehr-dominance-health-tech-antitrust-scrutiny/) 4. ![](https://www.statnews.com/wp-content/uploads/2026/10/AdobeStock_305447415-80x80.jpeg) ![](https://www.statnews.com/wp-content/themes/stat/images/home/statplus.svg) [HHS moves to allow compounding of some unapproved peptides](https://www.statnews.com/2026/10/28/hhs-enforcement-discretion-policy-allows-peptide-compounding/) 5. ![](https://www.statnews.com/wp-content/uploads/2024/03/Adams-Biotech-Scorecard-Featured-Image-80x80.jpg) ![](https://www.statnews.com/wp-content/themes/stat/images/home/statplus.svg) [Vertex kidney disease drug scrutinized for infection risk](https://www.statnews.com/2026/10/29/biotech-news-vertex-kidney-disease-drug-scrutinized-for-infection-risk/) #### [ Reports ](https://reports.statnews.com/) [ ![](https://www.statnews.com/wp-content/uploads/2026/08/2026_CancerReport_ReportCover-328x424.jpg) Explore Cancer’s transformational moments: KRAS, CAR-T, immunotherapy, and more ](https://reports.statnews.com/products/cancer-transformational-moments-advances-in-kras-car-t-immunotherapy) Advertisement #### [Events](https://www.statnews.com/events/) [ ![](https://www.statnews.com/wp-content/uploads/2026/09/TevaPF_Wordpress_CalendarImage-80x80.jpg) The Next Era of Biosimilars: Rewriting the Playbook Virtual Oct 19 ](https://www.statnews.com/event/next-era-of-biosimilars-rewriting-the-playbook/) [ ![](https://www.statnews.com/wp-content/uploads/2026/09/ESMORecap_Wordpress_CalendarImage-80x80.jpg) ESMO 2026: The STAT Recap Virtual Oct 29 ](https://www.statnews.com/event/esmo-2026-the-stat-recap/) [ ![](https://www.statnews.com/wp-content/uploads/2026/09/2026ASH_Wordpress_CalendarImage-80x80.jpg) STAT@ASH: Medicine’s Bleeding Edge New Orleans, LA Dec 13 ](https://www.statnews.com/event/stat-at-ash-meeting-2026/) Most Read in [STAT+](https://www.statnews.com/stat-plus/) 1. ![](https://www.statnews.com/wp-content/uploads/2026/10/C0614545-Rheumatoid_arthritis_light_micrograph-80x80.jpg) ![](https://www.statnews.com/wp-content/themes/stat/images/home/statplus.svg) [After two deaths in autoimmune cell therapy trial, Artiva is shutting down](https://www.statnews.com/2026/10/27/autoimmune-cell-therapy-trial-artiva-therapeutics-shutting-down/) 2. ![](https://www.statnews.com/wp-content/uploads/2026/10/AdobeStock_1846705681_Editorial_Use_Only-80x80.jpeg) ![](https://www.statnews.com/wp-content/themes/stat/images/home/statplus.svg) [Patient dies in Bristol Myers Squibb autoimmune CAR-T trial](https://www.statnews.com/2026/10/23/bristol-myers-squibb-car-t-therapy-autoimmune-trial-death/) 3. ![](https://www.statnews.com/wp-content/uploads/2025/05/AdobeStock_525738206_Editorial_Use_Only-80x80.jpeg) ![](https://www.statnews.com/wp-content/themes/stat/images/home/statplus.svg) [Detailed data confirm Moderna and Merck cancer vaccine met key endpoints in melanoma trial](https://www.statnews.com/2026/10/22/esmo-moderna-merck-cancer-vaccine-intismeran-data-released/) 4. ![](https://www.statnews.com/wp-content/uploads/2026/10/AdobeStock_499879090-80x80.jpeg) ![](https://www.statnews.com/wp-content/themes/stat/images/home/statplus.svg) [Tango reports 82% tumor response rate in trial of combo therapy for advanced pancreatic cancer](https://www.statnews.com/2026/10/23/esmo-2026-trial-results-tango-therapeutics-vopimetostat-revolution-medicines-rasonque/) 5. ![](https://www.statnews.com/wp-content/uploads/2023/08/31133231923_f179fd9d6d_o-80x80.jpg) ![](https://www.statnews.com/wp-content/themes/stat/images/home/statplus.svg) [Incyte pancreatic cancer medicine induces lasting tumor responses, company says at ESMO](https://www.statnews.com/2026/10/26/incyte-esmo-pancreatic-cancer-incb161734-results/) #### Recommended ![](https://www.statnews.com/wp-content/plugins/stat-lazy-load/images/328x185-00000000.png) Health Tech Newsletter Health Tech Newsletter October 22, 2026 ### ![](https://www.statnews.com/wp-content/themes/stat/images/home/statplus.svg) [ STAT Plus: FDA finalizes its guidance on apps related to drugs, pharma rejoices ](https://www.statnews.com/2026/10/22/fda-pdurs-guidance-dtx-telehealth-glp1-addiction-health-tech/) By [Mario Aguilar](https://www.statnews.com/staff/mario-aguilar/) ![](https://www.statnews.com/wp-content/plugins/stat-lazy-load/images/328x185-00000000.png) Health Tech Newsletter Health Tech Newsletter October 20, 2026 ### ![](https://www.statnews.com/wp-content/themes/stat/images/home/statplus.svg) [ STAT Plus: OpenEvidence’s JAMA paper leaves open questions ](https://www.statnews.com/2026/10/20/openevidence-jama-paper-leaves-open-questions-health-tech/) By [Mario Aguilar](https://www.statnews.com/staff/mario-aguilar/) Advertisement ![](https://www.statnews.com/wp-content/plugins/stat-lazy-load/images/328x185-00000000.png) Health Tech Newsletter Health Tech Newsletter October 15, 2026 ### ![](https://www.statnews.com/wp-content/themes/stat/images/home/statplus.svg) [ STAT Plus: ‘AI sandboxes’ are all the rage. Advocates scramble to control their future ](https://www.statnews.com/2026/10/15/scramble-to-shape-regulations-around-state-ai-sandboxes-health-tech/) By [Mario Aguilar](https://www.statnews.com/staff/mario-aguilar/) ![](https://www.statnews.com/wp-content/plugins/stat-lazy-load/images/328x185-00000000.png) Health Tech Newsletter Health Tech Newsletter October 13, 2026 ### ![](https://www.statnews.com/wp-content/themes/stat/images/home/statplus.svg) [ STAT Plus: Takeaways from an evaluation of Google’s diagnostic chatbot, AMIE ](https://www.statnews.com/2026/10/13/google-amie-diagnostic-chatbot-study-lancet-health-tech/) By [Mario Aguilar](https://www.statnews.com/staff/mario-aguilar/) ![](https://www.statnews.com/wp-content/plugins/stat-lazy-load/images/328x185-00000000.png) Health Tech Newsletter Health Tech Newsletter October 8, 2026 ### ![](https://www.statnews.com/wp-content/themes/stat/images/home/statplus.svg) [ STAT Plus: AI for breast cancer risk prediction goes DTC, regulatory cloud over Utah sandbox, and AI psychosis ](https://www.statnews.com/2026/10/08/breast-cancer-ai-goes-dtc-utah-sandbox-ai-psychosis-health-tech/) By [Mario Aguilar](https://www.statnews.com/staff/mario-aguilar/) #### Subscriber Picks 1. ### ![](https://www.statnews.com/wp-content/themes/stat/images/home/statplus.svg) [ STAT Plus: As Epic’s dominance grows, its iron grip is choking innovation in health technology ](https://www.statnews.com/2026/10/28/epic-systems-ehr-dominance-health-tech-antitrust-scrutiny/) By [Casey Ross](https://www.statnews.com/staff/casey-ross/) and [Brittany Trang](https://www.statnews.com/staff/brittany-trang/) 2. ### ![](https://www.statnews.com/wp-content/themes/stat/images/home/statplus.svg) [ STAT Plu
## Related Clinical Research

- [Democrats Win Congressional Control, Move to Reverse Trump Health Agenda](https://medichelpline.com/clinical-feed/stat-news-0-stat-democrats-win-power-to-push-back-on-trump-s-health-care-moves.md)
- [New DOL rule will force PBMs to disclose **drug rebates** and other secret payments](https://medichelpline.com/clinical-feed/stat-news-0-stat-new-federal-rule-will-require-prescription-drug-middlemen-to-share-secret.md)
- [Vitamin B5 derivative linked to reduced psoriasis plaques and inflammation in small trial](https://medichelpline.com/clinical-feed/medical-news-today-0-vitamin-b5-derivative-may-reduce-psoriasis-plaques-and-inflammation-small-trial.md)
- [Retatrutide: A New Approach for Easing Knee Osteoarthritis Pain](https://medichelpline.com/clinical-feed/medical-news-today-0-new-weight-loss-drug-eases-knee-osteoarthritis-pain-in-major-trials.md)

## Navigation
- [← Back to General Feed](https://medichelpline.com/clinical-feed/general.md)
- [← All Clinical Specialties](https://medichelpline.com/clinical-feed.md)
## Medical & Regulatory Disclaimer

> [!CAUTION]
> MedicHelpline content is structured for research, educational, and professional discovery purposes. It does not constitute individual medical advice, clinical diagnosis, or treatment recommendations.
> Always verify dosing, contraindications, and regulatory alerts against official product labeling and primary regulatory sources before clinical decision-making.